Connection
Thomas Campbell to Drug Resistance, Microbial
This is a "connection" page, showing publications Thomas Campbell has written about Drug Resistance, Microbial.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.008 |
|
|
|
-
Schooley RT, Campbell TB, Kuritzkes DR, Blaschke T, Stein DS, Rosandich ME, Phair J, Pottage JC, Messari F, Collier A, Kahn J. Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 01; 12(4):363-70.
Score: 0.008